ACCC association of cancer care centers
Join/Renew
Login
Join/Renew
Login
Education & Resources
ACCC eXchange LogInCorporate Member Sponsored ResourcesPresentations & AbstractsACCC Connect eLearning LogIn
Publications
Oncology IssuesPatient Assistance & Reimbursement GuideTrending Now in Cancer CareBusiness Case Studies for Hiring New Staff
Events
2026 ACCC Leadership SummitAnnual Meeting & Cancer Center Business SummitCapitol Hill DayNational Oncology ConferenceOncology Reimbursement MeetingsOncology State Society Meetings
Policy & Advocacy
ACCC 2026 Policy PrioritiesLetters & StatementsAccess, Payment & Reimbursement ReformWhite Bagging & Brown BaggingAdvocacy ResourcesCancer Moonshot
Membership
Join | RenewWho We AreMembership Types & BenefitsCorporate MembersACCC Member Portal FAQMember Directory
Partners
Oncology State SocietiesPartner OrganizationsCME
News
News ReleasesAdvocacy News ReleasesOncology News
About ACCC
Timeline / 50th Anniversary2025 Impact ReportPresident's ThemeACCC Innovator AwardsACCC FellowsBoard of TrusteesACCC Senior Staff
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
Join/Renew
Login
Breast CancerMetastatic Breast Cancer
Gastrointestinal CancerBiliary Tract CancerColorectal CancerGastric CancerLiver Cancer
Genitourinary CancerBladder CancerProstate CancerRenal Cell Carcinoma
Gynecologic CancerOvarian Cancer
Head & Neck Cancer
Hematologic MalignanciesAcute Lymphocytic Leukemia (ALL)Acute Myeloid Leukemia (AML)Chronic Lymphocytic Leukemia (CLL)Mantle Cell Lymphoma (MCL)Multiple Myeloma (MM)Myelodysplastic Syndromes (MDS)
Lung CancerNon-Small Cell Lung Cancer (NSCLC)Small Cell Lung Cancer (SCLC)
Sarcoma
Skin CancerMelanomaNon-Melanoma Skin Cancers (NMSC)
Clinical Practice & TreatmentCancer DiagnosticsCare CoordinationEHR Integration for Biomarker TestingQuality Improvement Collaboration: Integration of Precision Medicine in Community OncologyTreatment
Financial NavigationFAN Boot CampFinancial Advocacy Network (FAN) Resource LibraryPatient Assistance & Reimbursement GuidePrior Authorization
Health Equity & Access3, 2, 1, Go! Practical Solutions for Addressing Cancer Care DisparitiesAppalachian Community Cancer AllianceOncology Advanced PractitionersPersonalizing Care for Patients of All BackgroundsSocial Drivers of Health
Patient-Centered CareAddressing Care Disparities for VeteransAdolescent and Young Adult (AYA)Care Action Plans for People with CancerDermatologic ToxicitiesEmpowering CaregiversGeriatric OncologyHealth LiteracyNutritionOncology PharmacyPatient NavigationPsychosocial Care in OncologyShared Decision-MakingSupportive CareSurvivorship Care
Practice Management & OperationsCancer Program FundamentalsLeadership Sustainment and Engagement VideosOncology Practice Transformation and Integration CenterOncology Team Resiliency
ResearchACCC Community Oncology Research Institute (ACORI)
Technology & InnovationTelehealth & Digital Medicine
ACCCBuzz Blog
CANCER BUZZ Podcast
Oncology Issues
    • Education & Resources
    • Publications
    • Events
    • Policy & Advocacy
    • Membership
    • Partners
    • News
    • About ACCC
ACCC association of cancer care centers
1801 Research Boulevard, Suite 400, Rockville, MD 20850
Tel: 301.984.9496 Email Us
Contact UsVolunteers
Advertise
Career Center
Terms and Conditions
Privacy Policy
ACCC Rebranding
Copyright © 2026 Association of Cancer Care Centers. All Rights Reserved.
HomeACCCBuzz Blog

The Importance of Developing Health Equity Initiatives

February 7, 2024

Modern Healthcare's latest symposium on social drivers of health, gathered industry leaders to develop practical strategies for the promotion of health equity initiatives.

The Importance of Developing Health Equity Initiatives

This is the final post of a three-part series on Modern Healthcare’s Social Determinants of Health Symposium, which was held virtually on October 25, 2023. You can read the second one here.

The last decade has seen an increasing recognition within healthcare on the impact of social drivers of health (SDOH) have on the patient journey. In response, healthcare providers and policymakers have been exploring ways to address these social factors and promote health equity. Modern Healthcare's latest symposium on social determinants of health, gathered industry leaders to achieve this goal.

In delivering the first keynote address, Robert Garrett, CEO at Hackensack Meridian Health (HMH) said, “At the heart of social determinant of health strategies is the drive to improve health equity and build stronger communities. Think about creating a world where your zip code should never be an indicator of your health.”

Garrett highlighted health disparities in the United States by detailing the following statistics:

  • Black mothers are 3x more likely to die due to pregnancy complications compared to White mothers.
  • There is a 30-year gap in life expectancy between the world’s richest and poorest countries.
  • Life expectancy for Black Americans is 3.5 years less than White Americans.

HMH is comprised of a network of healthcare providers in New Jersey, including academic medical centers, acute care facilities, and research hospitals. It operates 17 hospitals and encompasses 36,000 employees.The program’s SDOH strategy focuses on screening for food insecurity, housing insecurity, and caregiver stress. Hackensack is making strides beyond traditional health care by utilizing new technology, an innovative strategy that has screened more than 800,000 patients and made 2.7 million referrals to social service agencies and redesigning medical education.

In concluding his address, Garrett shared HMH's ongoing and developing initiatives to promote health equity:

  • Secured $4M in state and federal grants as well as private philanthropy to directly fund purchases of healthy food for supplemental nutrition assistance program (SNAP) beneficiaries.
  • Addressing the physician shortage (in primary care and general surgery) by opening the first private medical school in New Jersey in 60 years.
  • Opening the first of its kind transportation and healthcare hub at one of the busiest train stations in the northeast corridor (Metropark) that will include physician offices, urgent care, among other services.

Following the keynote address, Member of the US House of Representative from Delaware, Lisa Blunt Rochester, provided an overview of how the US Congress is addressing health equity. Rochester noted that one of the first executive orders current US President, Joseph R. Biden, made was focused on examining federal health operations through a health equity lens. “Health equity is an issue that can unite us across the political divide,” Rochester said. She went on to highlight the work the Centers for Medicare & Medicaid Services (CMS) in the SDOH space as well as how private hospitals have begun reporting on the socioeconomic factors that influence patient care. “You are our best advocates. We need you to help educate the public and educate members of Congress. There are so much more we can do to close the gaps of health disparities,” Rochester concluded.

A Data-Driven Approach to Health Equity

Rochester’s keynote address was followed by a series of breakout sessions. The first featured a panel discussion moderated by Kat Jercich, senior editor at Modern Healthcare. The panelists included: Evelyn Gallego, CEO and Founder at EMI Advisors, Alric Simmonds, MD, chief health equity officer at AdventHealth, and Rachel Thorton, MD, vice president and chief health equity officer at Nemours Children’s Health.

The discussion focused on how healthcare organizations can adopt a data-driven approach towards promoting health equity. A few of steps highlighted involve aggregating and analyzing data to identify drivers of health outcome disparities among different populations, constructing a data governance framework, and developing practical tools to address disparities. “We have an obligation to understand what is going on in communities. That is, identifying things that impact health outcomes,” Dr. Simmonds said.

The Role of Leadership

Another key breakout session focused on how hospital and health system leaders play a pivotal role in ensuring everyone has fair and equitable access to healthcare. This discussion focused on prioritizing health equity efforts, even with continued challenges. Panelists included Allison Hess, vice president of health innovations at Geisinger, Anand Shah, MD, vice president of social health at Kaiser Permanente, Elsie Taveras, MD, chief community health and equity officer at Mass General Brigham, and Michael Zenn, senior advisor of enterprise strategic initiatives at the University of Illinois, Chicago. The session was moderated by Mary Ellen Podmolik, editor-in-chief at Modern Healthcare.

The conversation focused on how each institution has been working to embed health equity and SDOH efforts into everyday care. Dr. Taveres highlighted a program at Mass General Brigham titled, “United Against Racism.” According to Dr. Tavares, it serves as the Institution’s diversity, equity, and inclusion statement to address the impact of racism on patients, staff, and the community. With the backing of executive leaders, the program serves as a commitment to making facilities and services accessible and welcoming to all.

Closing Remarks

The day closed with a presentation from Kevin Mahoney, CEO, the University of Pennsylvania Health System. Mahoney described how the health system is working to bridge the health equity gap. He noted that approximately 75% of their revenue margin is used to support research and education. An example of the successful use of these research dollars includes the Penn Medicine scientists who were recently awarded the 2023 Nobel Prize in physiology and medicine for their work on the mRNA technology that was used to develop the COVID-19 vaccine.

Mahoney went on to highlight Heart Safe Motherhood. The text message-based program monitors a patient's blood pressure after they give birth, with the ease of communicating with a care team member from home. Mahoney noted that following program implementation, the University of Pennsylvania Health System has seen a dramatic decline (30%) in maternal morbidity and mortality rates in patients from underserved communities. “That is our why at Penn Medicine,” he said. “We want to change the world."

Related Content

Building a Blueprint for Precision Medicine: Lessons from TriHealthACCCBuzz Blog

Building a Blueprint for Precision Medicine: Lessons from TriHealth

June 25, 2026

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple MyelomaACCCBuzz Blog

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

June 22, 2026

15 Years Strong: The NCCN State Oncology Society Forum Annual MeetingACCCBuzz Blog

15 Years Strong: The NCCN State Oncology Society Forum Annual Meeting

Sean T. McCarson, MPA

June 16, 2026

Highlights from Volume 41, Number 3 Oncology IssuesACCCBuzz Blog

Highlights from Volume 41, Number 3 Oncology Issues

Gabrielle Stearns

June 15, 2026

ACCC Roundtable Series to Build a CAR T Multiple Myeloma Referral FrameworkACCCBuzz Blog

ACCC Roundtable Series to Build a CAR T Multiple Myeloma Referral Framework

Gabrielle Stearns

June 11, 2026

Precision Medicine Stewardship: Turning Complexity Into Coordinated Cancer CareACCCBuzz Blog

Precision Medicine Stewardship: Turning Complexity Into Coordinated Cancer Care

June 9, 2026

A Leadership Playbook for Responsible AI AdoptionACCCBuzz Blog

A Leadership Playbook for Responsible AI Adoption

June 4, 2026

Health Literacy in the Digital Age: An NCCN Policy SummitACCCBuzz Blog

Health Literacy in the Digital Age: An NCCN Policy Summit

Gabrielle Stearns

June 2, 2026

Upcoming Events

ACCC 43rd National Oncology Conference
Oncology

ACCC 43rd National Oncology Conference

In Person Conference & ConventionOctober 21, 2026 at 8:00 AM MDT450 Summer St, Boston, MA 02210Omni Boston Hotel at the Seaport, Boston
Register Now!
KaSCO 2026 Fellows Dinner
Oncology

KaSCO 2026 Fellows Dinner

In Person Conference & ConventionJuly 16, 2026 at 6:00 PM CDT101 West 22nd Street, Kansas City, MO, USALidia's Kansas City, Kansas City
Register Now!
MSCO 2026 Professional Development Workshop
Oncology

MSCO 2026 Professional Development Workshop

In Person Conference & ConventionJuly 18, 2026 at 3:30 PM CDT5005 Glumack Drive, Minneapolis, MN, USAInterContinental Hotel Minneapolis – St. Paul Airport, Minneapolis
Register Now!
NOS 2026 Dinner at the Las Vegas Best of ASCO
Oncology

NOS 2026 Dinner at the Las Vegas Best of ASCO

In Person Conference & ConventionJuly 24, 2026 at 5:30 PM PDT101 Montelago Blvd, Henderson, NV 89011, USAThe Westin Lake Las Vegas Resort & Spa , Henderson
Register Now!
WSMOS 2026 Dinner at the Seattle Best of ASCO
Oncology

WSMOS 2026 Dinner at the Seattle Best of ASCO

In Person Conference & ConventionJuly 24, 2026 at 5:30 PM PDT1415 5th Ave, Seattle, WA, USAHilton Motif Seattle, Seattle
Register Now!
KYSCO 2026 Tri-State Multi-Disciplinary Cancer Care Summit
Oncology

KYSCO 2026 Tri-State Multi-Disciplinary Cancer Care Summit

In Person Conference & ConventionJuly 25, 2026 at 7:30 AM EDT638 Madison Ave, Covington, Kentucky 41011, USAHotel Covington, Covington
Register Now!
HSCO 2026 August Dinner Symposium
Oncology

HSCO 2026 August Dinner Symposium

In Person Conference & ConventionAugust 12, 2026 at 5:30 PM HST6600 Kalanianaʻole Highway suite 110, Honolulu, HI 96825, USARoy's Restaurants – Hawaii Kai, Honolulu
Register Now!
LOS 2026 Cancer Congress - National Oncology Updates
Oncology

LOS 2026 Cancer Congress - National Oncology Updates

In Person Conference & ConventionAugust 14, 2026 at 11:00 AM CDT859 Convention Center Blvd, New Orleans, LA, USANew Orleans Marriott Warehouse Art District, New Orleans
Register Now!
Advertisement
Advertisement

Trending Now on
ACCCBuzz Blog

Building a Blueprint for Precision Medicine: Lessons from TriHealth

Building a Blueprint for Precision Medicine: Lessons from TriHealth

ACCC launched its Precision Medicine Stewardship Program to highlight institutions that have successfully built the infrastructure, workflows, and leadership models needed to deliver precision medicine at scale. TriHealth Cancer and Blood Institute in Cincinnati, Ohio, offers a compelling example of what it takes to move from aspiration to execution.

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

Exploring a Bispecific Antibody for Relapsed or Refractory Multiple Myeloma

Although patients with relapsed or refractory multiple myeloma now have more treatment options than ever, their journeys are often complex. As clinicians consider when to introduce newer therapies such as bispecific antibodies, they must account for prior treatments, treatment-related toxicities, and comorbidities that may impact treatment decisions.

15 Years Strong: The NCCN State Oncology Society Forum Annual Meeting

15 Years Strong: The NCCN State Oncology Society Forum Annual Meeting

Each year, the NCCN State Oncology Society Forum is thoughtfully organized to foster meaningful collaboration and forge common bonds to advance dignity and fair access to cancer care. In this blog, Sean T. McCarson shares key insights from stakeholders across the oncology policy landscape at this year's meeting.

Highlights from Volume 41, Number 3 Oncology Issues

Highlights from Volume 41, Number 3 Oncology Issues

The latest issue of Oncology Issues features key insights from the inaugural ACCC Leadership Summit, strategies to adjust to rising patient volumes and workforce strain, advanced practice leadership models, and more.

View All ACCCBuzz Blogs

Recently Heard on
CANCER BUZZ Podcast

Beyond Body Art: Restoring Wholeness Through Paramedical Tattooing - [Podcast] Ep. 238

Bridging Radiation and Oncology in SCLC Care - [Podcast] Ep. 237

Championing Bispecific Antibodies in the VA - [Podcast] Ep. 236

Data-Driven Toxicity Management for ADCs – [Video Podcast] Ep. 235

View All Podcasts

Latest from Oncology Issues

June 2026
June 2026
April 2026
February 2026
December 2025
October 2025
View All Oncology Issues

Join the Conversation

ACCC eXchange Digital Banner
Login